iReceptor Plus
Promoting Human
Immunological Data
Storage, Integration &
Controlled Sharing
iReceptor Plus
Promoting Human
Immunological Data
Storage, Integration &
Controlled Sharing
iReceptor Plus
Promoting Human
Immunological Data
Storage, Integration &
Controlled Sharing
iReceptor Plus
Promoting Human
Immunological Data
Storage, Integration &
Controlled Sharing
iReceptor Plus
Promoting Human
Immunological Data
Storage, Integration &
Controlled Sharing
iReceptor Plus
Promoting Human
Immunological Data
Storage, Integration &
Controlled Sharing
iReceptor Plus
Promoting Human
Immunological Data
Storage, Integration &
Controlled Sharing
iReceptor Plus
Promoting Human
Immunological Data
Storage, Integration &
Controlled Sharing
iReceptor Plus
Promoting Human
Immunological Data
Storage, Integration &
Controlled Sharing
iReceptor Plus will benefit
The project
The international iReceptor Plus consortium aims to promote human immunological data storage, integration and controlled sharing for a wide range of clinical and scientific purposes.
The four-year project, which is co-funded by the EU and Canadian government, aims to develop an innovative platform to integrate distributed repositories of Adaptive Immune Receptor Repertoire sequencing data.
News
December 6, 2022 –iReceptor Plus Offers Scientists Access to Single-Cell Immune Profiling Data
The international consortium revealed a new version of the iReceptor Plus Platform that can be used to develop new vaccines, monoclonal antibodies for cancer and autoimmune treatment.
Scientific Gateway
The iReceptor Plus Scientific Gateway is an excellent tool for detailed understanding of the basic biology underlying diseases of the adaptive immune system and is expected to lead to new vaccines, monoclonal antibodies for cancer and autoimmune treatment, and the many other diseases with a connection to the immune system.